Shkreli: No Regrets for Raising Drug Price

The transcript discusses the political silence on drug pricing during the Obama administration and the impact of drug price increases on business and investors. It explores the challenges of being a CEO in a capitalist society while dealing with government intervention. The speaker reflects on the risks posed by government actions and highlights achievements in drug development, despite public focus on a single drug.

What was the speaker's perspective on the impact of raising drug prices quickly?

What did the speaker imply about the public's perception of pharmaceutical companies?